Update on Indications for Percutaneous Renal Mass Biopsy in the Era of Advanced CT and MRI.
AJR Am J Roentgenol. 2019 Mar 27:1-10. doi: 10.2214/AJR.19.21093. [Epub ahead of print]
Lim CS1,2,3, Schieda N1,2,3, Silverman SG1,2,3.
OBJECTIVE: The objective of this article is to review the burgeoning role of percutaneous renal mass biopsy (RMB).
CONCLUSION: Percutaneous RMB is safe, accurate, and indicated for an expanded list of clinical scenarios. The chief scenarios among them are to prevent treatment of benign masses and help select patients for active surveillance (AS). Imaging characterization of renal masses has improved; however, management decisions often depend on a histologic diagnosis and an assessment of biologic behavior of renal cancers, both of which are currently best achieved with RMB.
Read Full Article Here: https://doi.org/10.2214/AJR.19.21093